🇺🇸 FDA
Patent

US 12383625

Polyoxazoline-drug conjugates with novel pharmacokinetic properties

granted A61KA61K31/05A61K47/59

Quick answer

US patent 12383625 (Polyoxazoline-drug conjugates with novel pharmacokinetic properties) held by Serina Therapeutics (AL), Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics (AL), Inc.
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/05, A61K47/59, A61P, A61P25/28